KLOW 80mg β Research Peptide Blend
Product Overview
KLOW 80mg is a multi-peptide research blend combining four peptides: GHK-Cu, BPC-157, TB-500, and KPV.
This formulation is intended for controlled laboratory investigation of peptide interactions, cellular signaling, and biochemical pathways associated with tissue biology.
Peptide Composition
Each vial contains:
- GHK-Cu β 50 mg: A copper-binding tripeptide investigated for its role in cellular signaling and extracellular matrix biology.
- BPC-157 β 10 mg: An experimental peptide studied in preclinical models involving cellular responses and tissue-related biological processes.
- TB-500 β 10 mg: A research peptide associated with investigations of thymosin beta-4-related biological pathways.
- KPV β 10 mg: A tripeptide investigated in preclinical research involving inflammatory signaling pathways.
Total Peptide Content: 80 mg per vial
Research Applications
Potential areas of laboratory investigation include:
- Peptide interactions and cellular signaling
- Extracellular matrix biology
- Cellular response mechanisms
- Inflammatory signaling pathways
- Peptide stability and molecular characterization
- Biochemical pathways associated with tissue biology
Product Specifications
- Product Name: KLOW
- Total Content: 80 mg
- Physical Form: Lyophilized powder
- Reported Purity: 99.88% (pending batch-specific COA verification)
- Storage: According to validated manufacturer specifications
- Intended Use: Laboratory research only
Quality & Testing
Batch-specific laboratory testing should verify the identity, quantity, and purity of each peptide component.
A Certificate of Analysis (COA) should document the analytical results and testing methods used. The reported purity of 99.88% should be supported by appropriate testing of the formulation.
Research Use Disclaimer
For laboratory research use only.
Not for human or veterinary consumption, injection, or therapeutic applications.
This formulation is not approved for clinical use.






Reviews
There are no reviews yet.